Jiangsu Hualan New Pharmaceutical Material Co Ltd
SZSE:301093
Jiangsu Hualan New Pharmaceutical Material Co Ltd
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. engages in the manufacture and production of direct or indirect pharmaceuticals contact injection drugs. The company is headquartered in Wuxi, Jiangsu and currently employs 861 full-time employees. The company went IPO on 2021-11-01. The Company’s main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The firm's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The firm also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The firm distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. engages in the manufacture and production of direct or indirect pharmaceuticals contact injection drugs. The company is headquartered in Wuxi, Jiangsu and currently employs 861 full-time employees. The company went IPO on 2021-11-01. The Company’s main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The firm's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The firm also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The firm distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.
